IDO1 and depressive symptom measurement: Since IDO1 plays a key role in the comorbidity of pain and depression in our previous study (Kim et al., 2012), we examined whether fluoxetine treatment would change the expression of 5-HT1A auto-receptors and IDO1 in the DRN.